
Retatrutide
Retatrutide — Research Grade Lyophilized Peptide
Retatrutide is the most advanced peptide architecture currently available for research. Retatrutide is a next-generation triple receptor agonist targeting GLP-1, GIP, and glucagon pathways simultaneously. This multi-receptor binding profile makes it a subject of active academic and preclinical investigation.
Purity & Verification
Each batch undergoes independent third-party HPLC analysis and mass spectometry sequence testing verification before release. Our current batch (GLPx Reta 30mg) achieved 99.98% purity, Full Certificate of Analysis is inluded with every order and permentantly accessible at glpxlabs.com/coa.
Legal & Compliance
This product is sold strictly for in-vitro laboratory research use only. Not approved for human or veterinary use. Not for consumption. Not a drug or supplement, These statements have not evaluated by the FDA. Researcher assumes full responsibility for compliance with applicable local, state, and federal regulations.